Adipose tissue derived stromal stem cell therapy in murine ConA-derived hepatitis is dependent on myeloid-lineage and CD4+ T-cell suppression

European Journal of Immunology

Volumn 43, Issue 11, 2013, Pages 2956-2968

  Higashimoto, Mami ^a   Sakai, Yoshio ^a,b   Takamura, Masayuki ^a   Usui, Soichiro ^a   Nasti, Alessandro ^a   Yoshida, Keiko ^a   Seki, Akihiro ^a   Komura, Takuya ^a   Honda, Masao ^b   Wada, Takashi ^a   Furuichi, Kengo ^b   Ochiya, Takahiro ^c   Kaneko, Shuichi ^a,b  

^a KANAZAWA UNIVERSITY   (Japan)

^b KANAZAWA UNIVERSITY HOSPITAL   (Japan)

^c NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

Adipose tissue derived stromal stem cells; Anti inflammatory effects; CD4+ T cells; ConA hepatitis; Myeloid lineage cells

Indexed keywords

CD11B ANTIGEN; CLODRONIC ACID; CONCANAVALIN A; GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR 1; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE TISSUE CELL; ADIPOSE TISSUE DERIVED STROMAL STEM CELL; ADIPOSE TISSUE DERIVED STROMAL STEM CELL THERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; BONE MARROW CELL; CD4+ T LYMPHOCYTE; CELL CULTURE; CELL DIFFERENTIATION; CELL LINEAGE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; INFLAMMATORY CELL; INJECTION; LIVER; MACROPHAGE; MALE; MEDIATOR; MOUSE; MURINE HEPATITIS; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; STEM CELL; STEM CELL TRANSPLANTATION; TISSUE REGENERATION;

ADIPOSE TISSUE DERIVED STROMAL STEM CELLS; ANTI-INFLAMMATORY EFFECTS; CD4+ T CELLS; CONA HEPATITIS; MYELOID-LINEAGE CELLS;

ADIPOSE TISSUE; ANIMALS; ANTIGENS, CD11B; ANTIGENS, DIFFERENTIATION; CD4-POSITIVE T-LYMPHOCYTES; CELL- AND TISSUE-BASED THERAPY; CONCANAVALIN A; DOWN-REGULATION; FEMALE; HEPATITIS, ANIMAL; INTERFERON-GAMMA; LIVER; LUNG; MACROPHAGES; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED C57BL; MYELOID CELLS; RECEPTORS, CHEMOKINE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84888058589     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201343531     Document Type: Article

References (27)

1. Zuk, P. A., Zhu, M., Ashjian, P., De Ugarte, D. A., Huang, J. I., Mizuno, H., Alfonso, Z. C. et al., Human adipose tissue is a source of multipotent stem cells. Mol. Biol. Cell 2002. 13: 4279-4295.
2. Chamberlain, G., Fox, J., Ashton, B. and Middleton, J., Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 2007. 25: 2739-2749.
3. Perez-Cano, R., Vranckx, J. J., Lasso, J. M., Calabrese, C., Merck, B., Milstein, A. M., Sassoon, E. et al., Prospective trial of adipose-derived regenerative cell (ADRC)-enriched fat grafting for partial mastectomy defects: the RESTORE-2 trial. Eur. J. Surg. Oncol. 2012. 38: 382-389.
4. Janssens, S., Stem cells in the treatment of heart disease. Annu. Rev. Med. 2010. 61: 287-300.
5. Hoogduijn, M. J., Popp, F., Verbeek, R., Masoodi, M., Nicolaou, A., Baan, C. and Dahlke, M. H., The immunomodulatory properties of mesenchymal stem cells and their use for immunotherapy. Int. Immunopharmacol. 2010. 10: 1496-1500.
6. Baroni, G. S., Pastorelli, A., Manzin, A., Benedetti, A., Marucci, L., Solforosi, L., Di Sario, A. et al., Hepatic stellate cell activation and liver fibrosis are associated with necroinflammatory injury and Th1-like response in chronic hepatitis C. Liver 1999. 19: 212-219.
7. Cerny, A. and Chisari, F. V., Pathogenesis of chronic hepatitis C: immunological features of hepatic injury and viral persistence. Hepatology 1999. 30: 595-601.
8. Gershwin, M. E., Ansari, A. A., Mackay, I. R., Nakanuma, Y., Nishio, A., Rowley, M. J. and Coppel, R. L., Primary biliary cirrhosis: an orchestrated immune response against epithelial cells. Immunol. Rev. 2000. 174: 210-225.
9. Krawitt, E. L., Autoimmune hepatitis. N. Engl. J. Med. 1996. 334: 897-903.
10. Fujii, H. and Kawada, N., Inflammation and fibrogenesis in steatohepatitis. J. Gastroenterol. 2012. 47: 215-225.
11. Dienes, H. P. and Drebber, U., Pathology of immune-mediated liver injury. Dig. Dis. 2010. 28: 57-62.
12. Dai, L. J., Li, H. Y., Guan, L. X., Ritchie, G. and Zhou, J. X., The therapeutic potential of bone marrow-derived mesenchymal stem cells on hepatic cirrhosis. Stem Cell Res. 2009. 2: 16-25.
13. Sanders, D. A., Moothoo, D. N., Raftery, J., Howard, A. J., Helliwell, J. R. and Naismith, J. H., The 1.2 A resolution structure of the Con A-dimannose complex. J. Mol. Biol. 2001. 310: 875-884.
14. Kato, M., Ikeda, N., Matsushita, E., Kaneko, S. and Kobayashi, K., Involvement of IL-10, an anti-inflammatory cytokine in murine liver injury induced by concanavalin A. Hepatol. Res. 2001. 20: 232-243.
15. Kubo, N., Narumi, S., Kijima, H., Mizukami, H., Yagihashi, S., Hakamada, K. and Nakane, A., Efficacy of adipose tissue-derived mesenchymal stem cells for fulminant hepatitis in mice induced by concanavalin A. J. Gastroenterol. Hepatol. 2012. 27: 165-172.
16. Murdoch, C., Muthana, M., Coffelt, S. B. and Lewis, C. E., The role of myeloid cells in the promotion of tumour angiogenesis. Nat. Rev. Cancer 2008. 8: 618-631.
17. Banas, A., Teratani, T., Yamamoto, Y., Tokuhara, M., Takeshita, F., Quinn, G., Okochi, H. et al., Adipose tissue-derived mesenchymal stem cells as a source of human hepatocytes. Hepatology 2007. 46: 219-228.
18. Kaneko, Y., Harada, M., Kawano, T., Yamashita, M., Shibata, Y., Gejyo, F., Nakayama, T. et al., Augmentation of Valpha14 NKT cell-mediated cytotoxicity by interleukin 4 in an autocrine mechanism resulting in the development of concanavalin A-induced hepatitis. J. Exp. Med. 2000. 191: 105-114.
19. Tiegs, G., Hentschel, J. and Wendel, A., A T cell-dependent experimental liver injury in mice inducible by concanavalin A. J. Clin. Invest. 1992. 90: 196-203.
20. Halder, R. C., Aguilera, C., Maricic, I. and Kumar, V., Type II NKT cell-mediated anergy induction in type I NKT cells prevents inflammatory liver disease. J. Clin. Invest. 2007. 117: 2302-2312.
21. Schwabe, R. F. and Brenner, D. A., Mechanisms of liver injury. I. TNF-alpha-induced liver injury: role of IKK, JNK, and ROS pathways. Am. J. Physiol. Gastrointest. Liver Physiol. 2006. 290: G583-G589.
22. Schumann, J., Wolf, D., Pahl, A., Brune, K., Papadopoulos, T., van Rooijen, N. and Tiegs, G., Importance of Kupffer cells for T-cell-dependent liver injury in mice. Am. J. Pathol. 2000. 157: 1671-1683.
23. Clegg, C. H., Rulffes, J. T., Wallace, P. M. and Haugen, H. S., Regulation of an extrathymic T-cell development pathway by oncostatin M. Nature 1996. 384: 261-263.
24. Constant, S. L. and Bottomly, K., Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches. Annu. Rev. Immunol. 1997. 15: 297-322.
25. Contento, R. L., Molon, B., Boularan, C., Pozzan, T., Manes, S., Marullo, S. and Viola, A., CXCR4-CCR5: a couple modulating T cell functions. Proc. Natl. Acad. Sci. USA 2008. 105: 10101-10106.
26. Ponte, A. L., Marais, E., Gallay, N., Langonne, A., Delorme, B., Herault, O., Charbord, P. et al., The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities. Stem Cells 2007. 25: 1737-1745.
27. Kushiyama, T., Oda, T., Yamada, M., Higashi, K., Yamamoto, K., Oshima, N., Sakurai, Y. et al., Effects of liposome-encapsulated clodronate on chlorhexidine gluconate-induced peritoneal fibrosis in rats. Nephrol. Dial. Transplant. 2011. 26: 3143-3154.